Articles from: CRXX (Combinatorx Inc) (MSN Money)
 |
|
|
|
|
| Next Page
| |
|
|
|
|
| CombinatoRx Reports Financial Results for the Second Quarter 2010 (more) | 2010 08 05 |
|
|
|
|
|
|
|
| CombinatoRx to Present at the Noble Financial Sixth Annual Equity Conferenc (more) | 2010 05 27 |
|
|
| CombinatoRx Reports Financial Results for the First Quarter 2010 (more) | 2010 05 06 |
|
| BioPharma Stock Alert for CombinatoRx Inc. Issued by MicroStockProfit (more) | 2010 05 05 |
|
| CombinatoRx to Present Data for Oncology Programs at American Association f (more) | 2010 04 15 |
|
|
| CombinatoRx Discovers Novel Multi-Target Mechanism for the Treatment of Hem (more) | 2010 04 14 |
|
| Liberty Analytics Co. Initiates Independent Research Coverage on CombinatoR (more) | 2010 03 26 |
|
| CombinatoRx Reports Financial Results for the Fourth Quarter and Year-End 2 (more) | 2010 03 25 |
|
|
| CombinatoRx to Webcast Conference Call Discussing Fourth Quarter and Year E (more) | 2010 03 18 |
|
| Biopharma Stock Alert for CombinatoRx Inc. Issued by Beacon Equity (more) | 2010 03 04 |
|
|
|
|
|
|
| CombinatoRx Announces Extension of Exalgo™ Extended-Release Tablets PDUFA (more) | 2010 02 17 |
|
| Biopharmaceutical Stock Alert for CombinatoRx Inc. Issued by InvestorSoup (more) | 2010 02 16 |
|
| Emerging Stock Report Initiates Independent Research Coverage on CombinatoR (more) | 2010 01 28 |
|
|
|
|
|
|
| CombinatoRx Oncology Programs Demonstrate Synergistic Anti-Cancer Activity (more) | 2009 12 18 |
|
|
|
|
|
|
| Neuromed Receives FDA Feedback on New Drug Application for Exalgo Extended- (more) | 2009 11 16 |
|
| CombinatoRx Reports Financial Results for the Third Quarter 2009 (more) | 2009 11 16 |
|
|
|
|
| UPDATE 1-CombinatoRx: Knee-pain drug effective through 12 months (more) | 2009 11 03 |
|
| CombinatoRx'S Synavive (CRx-102) Maintains Efficacy Throughout 12 Month Pha (more) | 2009 10 21 |
|
|
| Next Page
| |